CONTINUOUS VERSUS DISCONTINUOUS ANTIBIOTIC-THERAPY - THE ROLE OF THE POSTANTIBIOTIC EFFECT AND OTHER FACTORS

被引:17
作者
DAIKOS, GK
机构
[1] Athens 106 74
关键词
D O I
10.1093/jac/27.2.157
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:157 / 160
页数:4
相关论文
共 27 条
[1]   POSTANTIBIOTIC EFFECT OF IMIPENEM ON GRAM-POSITIVE AND GRAM-NEGATIVE MICROORGANISMS [J].
BAQUERO, F ;
CULEBRAS, E ;
PATRON, C ;
PEREZDIAZ, JC ;
MEDRANO, JC ;
VICENTE, MF .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :47-59
[2]   PENETRATION OF CEFIXIME INTO FIBRIN CLOTS AND INVIVO EFFICACY AGAINST ESCHERICHIA-COLI, KLEBSIELLA-PNEUMONIAE, AND STAPHYLOCOCCUS-AUREUS [J].
BERGERON, MG ;
TURCOTTE, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (06) :913-916
[3]  
BERGERON MG, 1981, REV INFECT DIS, V3, P84
[4]   COMPARATIVE-STUDY WITH ENOXACIN AND NETILMICIN IN A PHARMACODYNAMIC MODEL TO DETERMINE IMPORTANCE OF RATIO OF ANTIBIOTIC PEAK CONCENTRATION TO MIC FOR BACTERICIDAL ACTIVITY AND EMERGENCE OF RESISTANCE [J].
BLASER, J ;
STONE, BB ;
GRONER, MC ;
ZINNER, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1054-1060
[5]   EFFICACY OF INTERMITTENT VERSUS CONTINUOUS ADMINISTRATION OF NETILMICIN IN A 2-COMPARTMENT INVITRO MODEL [J].
BLASER, J ;
STONE, BB ;
ZINNER, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :343-349
[6]   ROLE OF AUTOLYSINS IN THE ACTIVITIES OF IMIPENEM AND CGP-31608, A NOVEL PENEM, AGAINST SLOWLY GROWING BACTERIA [J].
COZENS, RM ;
MARKIEWICZ, Z ;
TUOMANEN, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) :1819-1821
[7]   THE POSTANTIBIOTIC EFFECT [J].
CRAIG, WA ;
VOGELMAN, B .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :900-902
[8]  
DAIKOS G K, 1960, Arch Hyg Bakteriol, V144, P606
[9]   MIKROBIELLE PERSISTENZ STUDIERT INVIVO DURCH ANWENDUNG KUNSTLICHER FIBRINGERINNSEL .1. WACHSTUM VON BAKTERIEN IN DEN FIBRINGERINNSELN - STREPTOCOCCUS VIRIDANS-PERSISTENZ NACH PENICILLIN-VERABREICHUNG [J].
DAIKOS, GK ;
WEINSTEIN, L .
KLINISCHE WOCHENSCHRIFT, 1960, 38 (11) :521-528
[10]  
DEVRIES PJ, 1990, EUR J CLIN MICROBIOL, V9, P161